Smith & Nephew PLC Sponsored ADR Aktie News
29,00 €
0,47 %
heute
L&S,
13. Januar, 07:39 Uhr
Index
Industrie
tracken
Smith & Nephew PLC Sponsored ADR Aktie News
Positiv
Reuters
●
etwa 13 Stunden alt
British medical products maker Smith & Nephew will buy U.S.-based Integrity Orthopaedics in a deal that could be valued at up to $450 million, the company said on Monday.
Positiv
Seeking Alpha
●
5 Tage alt
Smith & Nephew has outperformed peers, driven by strong sports medicine and wound care, despite ongoing ortho business challenges. SNN's major joints segment remains a sore spot, with ongoing underperformance in knees and threats from Stryker's increased focus on ASCs. Management's 6–7% annualized growth guidance through 2028 is ambitious; I expect 5%+ growth with 2-3 points of adjusted EBITDA ...
Neutral
Seeking Alpha
●
etwa ein Monat alt
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
Neutral
Seeking Alpha
●
etwa ein Monat alt
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
Negativ
Proactive Investors
●
etwa ein Monat alt
Smith & Nephew PLC's (LSE:SN) new strategic plan and 2028 outlook look ambitious, City analysts said, but have been received with some heavy dashes of scepticism. UBS, which kept its rating on the shares at 'neutral' and set a 1,290p price target versus a last close at 1,265p, said treating the targets with caution is warranted as the company has achieved growth of over 6% only six times in the...
Positiv
Proactive Investors
●
etwa ein Monat alt
Smith & Nephew PLC (LSE:SN) has launched a new corporate strategy designed to give stronger returns for shareholders, alongside issuing medium-term financial targets through to 2028, alongside updated guidance for 2025 and a provisional outlook for accelerating growth in 2026. The knee and hip replacement company named the strategy RISE, as it will drive improved financial and operational perfo...
Positiv
Reuters
●
etwa ein Monat alt
British medical products maker Smith & Nephew raised its 2025 free cash flow forecast to around $800 million and unveiled new medium-term targets ahead of its Capital Markets Day Event on Monday.
Negativ
Proactive Investors
●
2 Monate alt
For a business built on orthopaedics and wound care, Smith & Nephew PLC (LSE:SN) has given investors a fair bit of whiplash. Its third-quarter update sent the shares down about 10% after organic revenue growth came in weaker than hoped and, crucially, slowed from the second quarter despite earlier guidance that it would accelerate.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
